Additional longitudinal studies on large MPN patient cohorts are now warranted to provide a complete immunological characterization of circulating MPN-specific T cells (i.e., both CD4+ and CD8+ memory T cell immunoprofiling for the production of different cytokines and functional subsets). The gene discussed is CD8A; the disease is myeloproliferative disorder.